HEXAVALENT VACCINE CASE
Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highPanacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involve...
Panacea, Sanofi settle patent litigation over hexavalent vaccinePanacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Sh...
Panacea Biotec files suit against Sanofi for patent infringement"The suit filed against Sanofi comes at the heels of Sanofi having received marketing approval for a Whole Cell Pertussis based Hexavalent ...
- Load More